The T-cell chemokine receptor CXCR3 is expressed highly in low-grade mycosis fungoides.
暂无分享,去创建一个
D. Dorfman | L. Medeiros | M. Duvic | D. Jones | R. Luthra | D. Lu
[1] D. Dorfman,et al. Recurrences in nodal T-cell lymphoma. Changes in histologic appearance and immunophenotype over the course of disease. , 2000, American journal of clinical pathology.
[2] D. Dorfman,et al. Expression pattern of T-cell-associated chemokine receptors and their chemokines correlates with specific subtypes of T-cell non-Hodgkin lymphoma. , 2000, Blood.
[3] M. Piris,et al. p16(INK4a) gene alterations are frequent in lesions of mycosis fungoides. , 2000, The American journal of pathology.
[4] Weiqi Wang,et al. Cutting Edge: The Orphan Chemokine Receptor G Protein-Coupled Receptor-2 (GPR-2, CCR10) Binds the Skin-Associated Chemokine CCL27 (CTACK/ALP/ILC)1 , 2000, The Journal of Immunology.
[5] Yu Wang,et al. Cutting Edge: Identification of a Novel Chemokine Receptor That Binds Dendritic Cell- and T Cell-Active Chemokines Including ELC, SLC, and TECK , 2000, The Journal of Immunology.
[6] D. Dorfman,et al. The chemokine receptor CXCR3 is expressed in a subset of B-cell lymphomas and is a marker of B-cell chronic lymphocytic leukemia. , 2000, Blood.
[7] N. Copeland,et al. CTACK, a skin-associated chemokine that preferentially attracts skin-homing memory T cells. , 1999, Proceedings of the National Academy of Sciences of the United States of America.
[8] R. Nibbs,et al. ESkine, a Novel β-Chemokine, Is Differentially Spliced to Produce Secretable and Nuclear Targeted Isoforms* , 1999, The Journal of Biological Chemistry.
[9] R. Suzuki,et al. Molecular cloning of a novel CC chemokine, interleukin‐11 receptor α‐locus chemokine (ILC), which is located on chromosome 9p13 and a potential homologue of a CC chemokine encoded by molluscum contagiosum virus , 1999, FEBS letters.
[10] J. Flier,et al. The CXCR3 activating chemokines IP-10, Mig, and IP-9 are expressed in allergic but not in irritant patch test reactions. , 1999, The Journal of investigative dermatology.
[11] James J. Campbell,et al. The chemokine receptor CCR4 in vascular recognition by cutaneous but not intestinal memory T cells , 1999, Nature.
[12] L. Trentin,et al. The chemokine receptor CXCR3 is expressed on malignant B cells and mediates chemotaxis. , 1999, The Journal of clinical investigation.
[13] J. Flier,et al. IP-10 mRNA expression in cultured keratinocytes is suppressed by inhibition of protein kinase-C and tyrosine kinase and elevation of cAMP. , 1999, Cytokine.
[14] R. Hromas,et al. Isolation of ALP, a novel divergent murine CC chemokine with a unique carboxy terminal extension. , 1999, Biochemical and biophysical research communications.
[15] R. Leurs,et al. Human IP-9: A keratinocyte-derived high affinity CXC-chemokine ligand for the IP-10/Mig receptor (CXCR3). , 1999, The Journal of investigative dermatology.
[16] C. Meijer,et al. Expression of cytotoxic proteins by neoplastic T cells in mycosis fungoides increases with progression from plaque stage to tumor stage disease. , 1999, The American journal of pathology.
[17] Z. Estrov,et al. Dysregulated Synthesis of Intracellular Type 1 and Type 2 Cytokines by T Cells of Patients with Cutaneous T-Cell Lymphoma , 1999, Clinical Diagnostic Laboratory Immunology.
[18] R. Kurzrock,et al. Transformation of mycosis fungoides/Sezary syndrome: clinical characteristics and prognosis. , 1998, Blood.
[19] P. V. Stoop,et al. Epidermal Interferon-γ Inducible Protein-10 (IP-10) and Monokine Induced by γ-Interferon (Mig) but not IL-8 mRNA Expression is Associated with Epidermotropism in Cutaneous T Cell Lymphomas , 1998 .
[20] C. Felix,et al. Overexpression of p53 protein in cutaneous T cell lymphoma: relationship to large cell transformation and disease progression. , 1998, The Journal of investigative dermatology.
[21] C. Mackay,et al. Flexible Programs of Chemokine Receptor Expression on Human Polarized T Helper 1 and 2 Lymphocytes , 1998, The Journal of experimental medicine.
[22] C. Mackay,et al. The chemokine receptors CXCR3 and CCR5 mark subsets of T cells associated with certain inflammatory reactions. , 1998, The Journal of clinical investigation.
[23] D. Steiner,et al. Cloning, expression, and chromosomal mapping of a novel human CC-chemokine receptor (CCR10) that displays high-affinity binding for MCP-1 and MCP-3. , 1997, DNA and cell biology.
[24] R. Martí,et al. T-cell population of primary and secondary cutaneous B-cell lymphomas does not express the cutaneous lymphocyte-associated antigen (CLA) , 1997, Archives of Dermatological Research.
[25] A. Zelenetz,et al. Interferon-inducible protein 10 as a possible factor in the pathogenesis of cutaneous T-cell lymphomas. , 1997, Clinical cancer research : an official journal of the American Association for Cancer Research.
[26] A. Deisseroth,et al. Cytokine loops involving interferon-gamma and IP-10, a cytokine chemotactic for CD4+ lymphocytes: an explanation for the epidermotropism of cutaneous T-cell lymphoma? , 1995, Blood.
[27] M. Bagot,et al. Cutaneous T-cell infiltrates: analysis of T-cell receptor gamma gene rearrangement by polymerase chain reaction and denaturing gradient gel electrophoresis. , 1995, Blood.
[28] P. E. Shapiro,et al. The Histologic Spectrum of Mycosis Fungoides/Sézary Syndrome (Cutaneous T‐Cell Lymphoma): A Review of 222 Biopsies, Including Newly Described Patterns and the Earliest Pathologic Changes , 1994, The American journal of surgical pathology.
[29] P. Heerde,et al. Differential expression of the HECA‐452 antigen (cutaneous lymphocyte associated antigen, CLA) in cutaneous and non‐cutaneous T‐cell lymphomas , 1992, Histopathology.
[30] M. Kadin. Lymphomatoid papulosis, Ki-1+ lymphoma, and primary cutaneous Hodgkin's disease. , 1991, Seminars in dermatology.
[31] L. King,et al. Clinical features associated with transformation of cerebriform T‐cell lymphoma to a large cell process , 1990, Hematological oncology.
[32] J. Greer,et al. Transformation of cutaneous T cell lymphoma to large cell lymphoma. A clinicopathologic and immunologic study. , 1988, The American journal of pathology.
[33] J. Ravetch,et al. Biochemical characterization of a gamma interferon-inducible cytokine (IP-10) , 1987, The Journal of experimental medicine.
[34] M. Reiss,et al. Interferon-inducible protein-10 and the pathogenesis of cutaneous T-cell lymphomas. , 1996, Leukemia & lymphoma.